Table 2.

—Lung function tests.

N = 136	Baseline	Post-Omalizumab	Difference	% Difference	P- value
Mean FEV1(% predicted)
16 weeks (n = 111)	62.94	70.98	8.05	12.8%	<.001
Most recent (approx. 12 months) (n = 32)	69.90	78.60	8.70	12.4%	.0020
Mean FEV1(L)
16 weeks (n = 88)	1.99	2.10	0.10	5.5%	.2157
Most recent (approx. 12 months) (n = 70)	1.99	2.22	0.24	12.1%	<.001
Mean PEF(L/min)
16 weeks (n = 91)	296.89	348.51	51.62	17.4%	<.001
Most recent (approx. 12 months) (n = 58)	299.24	326.79	27.55	9.2%	.0040